Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A Commentary on the NIH Consensus Development Statement 'Genetic Testing for Cystic Fibrosis'.

J Schmidtke1

  • 1Institute of Human Genetics, Hannover Medical School, Hannover, Germany. schmidtke.joerg@mh-hannover.de

Community Genetics
|June 5, 2004
PubMed
Summary

The NIH recommends cystic fibrosis carrier screening for all pregnant individuals, but evidence on uptake, risks, and optimal education is lacking. This recommendation is considered premature and not fully supported by current data.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The potential benefits of genetic testing in breast and ovarian cancer.

Saudi medical journal·2016
Same author

[Concepts for the return of secondary genetic findings in medical diagnostics and research].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2014
Same author

Health needs assessment for medical genetic services for congenital disorders in middle- and low-income nations.

Journal of community genetics·2013
Same author

International variation in physicians' attitudes towards prophylactic mastectomy - comparison between France, Germany, the Netherlands and the United Kingdom.

European journal of cancer (Oxford, England : 1990)·2013
Same author

Evaluation of Clinical Manifestations in Patients with Severe Lymphedema with and without CCBE1 Mutations.

Molecular syndromology·2013
Same author

[Health insurance companies and medical genetics, what do they want to know? Expert opinions concerning medical genetic services].

Versicherungsmedizin·2012

Area of Science:

  • Medical Genetics
  • Public Health Policy
  • Reproductive Medicine

Background:

  • A National Institutes of Health (NIH) Consensus Development Statement advocates for widespread cystic fibrosis carrier screening.
  • This recommendation targets the general pregnant and pre-pregnant population.
  • The statement's basis requires critical evaluation due to data limitations.

Purpose of the Study:

  • To critically assess the NIH recommendation for universal cystic fibrosis carrier screening.
  • To identify gaps in knowledge regarding screening implementation.
  • To evaluate the evidence supporting the recommendation's timing and scope.

Main Methods:

  • Review of existing literature and pilot project data on cystic fibrosis carrier screening.

Related Experiment Videos

  • Analysis of psychological and social risks associated with genetic screening.
  • Evaluation of optimal educational and counseling strategies for screening programs.

    • Main Results:

    • Significant lack of data concerning the drivers of high uptake rates in pilot screening projects.
    • Insufficient information on the psychological and social risks pertinent to widespread screening.
    • Uncertainty regarding the most effective educational and counseling frameworks for implementation.

    Conclusions:

    • The NIH recommendation for universal cystic fibrosis carrier screening is not adequately supported by current evidence.
    • The recommendation is considered premature due to insufficient data on key implementation factors.
    • Further research is needed to address data gaps before widespread implementation can be justified.